Serveur d'exploration sur le suicide chez les dentistes

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial.

Identifieur interne : 000331 ( Main/Exploration ); précédent : 000330; suivant : 000332

Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial.

Auteurs : Gary Hildebrandt [États-Unis] ; Ignatius Lee ; James Hodges

Source :

RBID : pubmed:20415801

Descripteurs français

English descriptors

Abstract

Xylitol-sweetened chewing gum has cariostatic properties, but is not suitable for all patients. This study evaluated the effect of xylitol rinse on mutans streptococci (MS) levels in the mouth. One hundred and five subjects with high salivary MS levels were randomly assigned to one of three groups. Subjects in the positive control group (N = 35) chewed two xylitol gum pellets for at least 5 minutes three times daily (xylitol dose: 4.3g/day). The experimental group (N = 36) rinsed with 20 mL of an aqueous solution of xylitol twice daily for 60 seconds (dose: 4.4 g/day). The negative control group (N = 34) used neither product. No attempt was made to change the subjects' diet. Mean MS levels at baseline were 5.6 (0.1) in positive control, 5.4 (0.1) in experimental, and 5.5 (0.1) in negative control groups. After 3 months, MS levels were 4.4 (0.2), 4.4 (0.2), and 4.9 (0.2), respectively. Differences between groups were not significant by ANOVA (p = .2); however, MS levels tended to be lower in the experimental and positive control groups. Xylitol rinse and chewing gum caused a similar but statistically insignificant reduction in MS levels in the mouth.

DOI: 10.1111/j.1754-4505.2009.00124.x
PubMed: 20415801


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial.</title>
<author>
<name sortKey="Hildebrandt, Gary" sort="Hildebrandt, Gary" uniqKey="Hildebrandt G" first="Gary" last="Hildebrandt">Gary Hildebrandt</name>
<affiliation wicri:level="2">
<nlm:affiliation>University of Minnesota School of Dentistry, Minneapolis, Minnesota, USA. hilde014@umn.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Minnesota School of Dentistry, Minneapolis, Minnesota</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Ignatius" sort="Lee, Ignatius" uniqKey="Lee I" first="Ignatius" last="Lee">Ignatius Lee</name>
</author>
<author>
<name sortKey="Hodges, James" sort="Hodges, James" uniqKey="Hodges J" first="James" last="Hodges">James Hodges</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010 Mar-Apr</date>
<idno type="RBID">pubmed:20415801</idno>
<idno type="pmid">20415801</idno>
<idno type="doi">10.1111/j.1754-4505.2009.00124.x</idno>
<idno type="wicri:Area/Main/Corpus">000340</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000340</idno>
<idno type="wicri:Area/Main/Curation">000340</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000340</idno>
<idno type="wicri:Area/Main/Exploration">000340</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial.</title>
<author>
<name sortKey="Hildebrandt, Gary" sort="Hildebrandt, Gary" uniqKey="Hildebrandt G" first="Gary" last="Hildebrandt">Gary Hildebrandt</name>
<affiliation wicri:level="2">
<nlm:affiliation>University of Minnesota School of Dentistry, Minneapolis, Minnesota, USA. hilde014@umn.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Minnesota School of Dentistry, Minneapolis, Minnesota</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Ignatius" sort="Lee, Ignatius" uniqKey="Lee I" first="Ignatius" last="Lee">Ignatius Lee</name>
</author>
<author>
<name sortKey="Hodges, James" sort="Hodges, James" uniqKey="Hodges J" first="James" last="Hodges">James Hodges</name>
</author>
</analytic>
<series>
<title level="j">Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry</title>
<idno type="eISSN">1754-4505</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Cariostatic Agents (therapeutic use)</term>
<term>Chewing Gum (MeSH)</term>
<term>Colony Count, Microbial (MeSH)</term>
<term>DMF Index (MeSH)</term>
<term>Double-Blind Method (MeSH)</term>
<term>Female (MeSH)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Mouthwashes (therapeutic use)</term>
<term>Patient Compliance (MeSH)</term>
<term>Pilot Projects (MeSH)</term>
<term>Saliva (metabolism)</term>
<term>Saliva (microbiology)</term>
<term>Secretory Rate (physiology)</term>
<term>Streptococcus mutans (drug effects)</term>
<term>Streptococcus mutans (growth & development)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Xylitol (therapeutic use)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Bains de bouche (usage thérapeutique)</term>
<term>Cariostatiques (usage thérapeutique)</term>
<term>Débit sécrétoire (physiologie)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Gomme à mâcher (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Indice DCAO (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Méthode en double aveugle (MeSH)</term>
<term>Numération de colonies microbiennes (MeSH)</term>
<term>Observance par le patient (MeSH)</term>
<term>Projets pilotes (MeSH)</term>
<term>Salive (microbiologie)</term>
<term>Salive (métabolisme)</term>
<term>Streptococcus mutans (croissance et développement)</term>
<term>Streptococcus mutans (effets des médicaments et des substances chimiques)</term>
<term>Sujet âgé (MeSH)</term>
<term>Xylitol (usage thérapeutique)</term>
<term>Études de suivi (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Cariostatic Agents</term>
<term>Mouthwashes</term>
<term>Xylitol</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr">
<term>Streptococcus mutans</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Streptococcus mutans</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Streptococcus mutans</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en">
<term>Streptococcus mutans</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Salive</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Salive</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Débit sécrétoire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Secretory Rate</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Bains de bouche</term>
<term>Cariostatiques</term>
<term>Xylitol</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Chewing Gum</term>
<term>Colony Count, Microbial</term>
<term>DMF Index</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Patient Compliance</term>
<term>Pilot Projects</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Gomme à mâcher</term>
<term>Humains</term>
<term>Indice DCAO</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Numération de colonies microbiennes</term>
<term>Observance par le patient</term>
<term>Projets pilotes</term>
<term>Sujet âgé</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Xylitol-sweetened chewing gum has cariostatic properties, but is not suitable for all patients. This study evaluated the effect of xylitol rinse on mutans streptococci (MS) levels in the mouth. One hundred and five subjects with high salivary MS levels were randomly assigned to one of three groups. Subjects in the positive control group (N = 35) chewed two xylitol gum pellets for at least 5 minutes three times daily (xylitol dose: 4.3g/day). The experimental group (N = 36) rinsed with 20 mL of an aqueous solution of xylitol twice daily for 60 seconds (dose: 4.4 g/day). The negative control group (N = 34) used neither product. No attempt was made to change the subjects' diet. Mean MS levels at baseline were 5.6 (0.1) in positive control, 5.4 (0.1) in experimental, and 5.5 (0.1) in negative control groups. After 3 months, MS levels were 4.4 (0.2), 4.4 (0.2), and 4.9 (0.2), respectively. Differences between groups were not significant by ANOVA (p = .2); however, MS levels tended to be lower in the experimental and positive control groups. Xylitol rinse and chewing gum caused a similar but statistically insignificant reduction in MS levels in the mouth.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20415801</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>07</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1754-4505</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>30</Volume>
<Issue>2</Issue>
<PubDate>
<MedlineDate>2010 Mar-Apr</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry</Title>
<ISOAbbreviation>Spec Care Dentist</ISOAbbreviation>
</Journal>
<ArticleTitle>Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial.</ArticleTitle>
<Pagination>
<MedlinePgn>53-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1754-4505.2009.00124.x</ELocationID>
<Abstract>
<AbstractText>Xylitol-sweetened chewing gum has cariostatic properties, but is not suitable for all patients. This study evaluated the effect of xylitol rinse on mutans streptococci (MS) levels in the mouth. One hundred and five subjects with high salivary MS levels were randomly assigned to one of three groups. Subjects in the positive control group (N = 35) chewed two xylitol gum pellets for at least 5 minutes three times daily (xylitol dose: 4.3g/day). The experimental group (N = 36) rinsed with 20 mL of an aqueous solution of xylitol twice daily for 60 seconds (dose: 4.4 g/day). The negative control group (N = 34) used neither product. No attempt was made to change the subjects' diet. Mean MS levels at baseline were 5.6 (0.1) in positive control, 5.4 (0.1) in experimental, and 5.5 (0.1) in negative control groups. After 3 months, MS levels were 4.4 (0.2), 4.4 (0.2), and 4.9 (0.2), respectively. Differences between groups were not significant by ANOVA (p = .2); however, MS levels tended to be lower in the experimental and positive control groups. Xylitol rinse and chewing gum caused a similar but statistically insignificant reduction in MS levels in the mouth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hildebrandt</LastName>
<ForeName>Gary</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>University of Minnesota School of Dentistry, Minneapolis, Minnesota, USA. hilde014@umn.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Ignatius</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hodges</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Spec Care Dentist</MedlineTA>
<NlmUniqueID>8103755</NlmUniqueID>
<ISSNLinking>0275-1879</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002327">Cariostatic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002638">Chewing Gum</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009067">Mouthwashes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VCQ006KQ1E</RegistryNumber>
<NameOfSubstance UI="D014993">Xylitol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>D</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002327" MajorTopicYN="N">Cariostatic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002638" MajorTopicYN="N">Chewing Gum</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015169" MajorTopicYN="N">Colony Count, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004245" MajorTopicYN="N">DMF Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009067" MajorTopicYN="N">Mouthwashes</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012636" MajorTopicYN="N">Secretory Rate</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013295" MajorTopicYN="N">Streptococcus mutans</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014993" MajorTopicYN="N">Xylitol</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>4</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>4</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20415801</ArticleId>
<ArticleId IdType="pii">SCD124</ArticleId>
<ArticleId IdType="doi">10.1111/j.1754-4505.2009.00124.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Minnesota</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Hodges, James" sort="Hodges, James" uniqKey="Hodges J" first="James" last="Hodges">James Hodges</name>
<name sortKey="Lee, Ignatius" sort="Lee, Ignatius" uniqKey="Lee I" first="Ignatius" last="Lee">Ignatius Lee</name>
</noCountry>
<country name="États-Unis">
<region name="Minnesota">
<name sortKey="Hildebrandt, Gary" sort="Hildebrandt, Gary" uniqKey="Hildebrandt G" first="Gary" last="Hildebrandt">Gary Hildebrandt</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000331 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000331 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SuicidDentistV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:20415801
   |texte=   Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20415801" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SuicidDentistV1 

Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Sun Oct 3 17:04:29 2021. Site generation: Sun Oct 3 17:05:17 2021